FALAGARIO, UGO GIOVANNI
FALAGARIO, UGO GIOVANNI
A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques
2022-01-01 D'Altilia, N; Mancini, V; Falagario, Ug; Martino, L; Di Nauta, M; Calò, B; Del Giudice, F; Basran, S; Chung, Bi; Porreca, A; Bianchi, L; Schiavina, R; Brunocilla, E; Busetto, Gm; Bettocchi, C; Annese, P; Cormio, L; Carrieri, G.
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data
2021-01-01 Maggi, M; Salciccia, S; Del Giudice, F; Busetto, Gm; Falagario, Ug; Carrieri, G; Ferro, M; Porreca, A; Di Pierro, Gb; Fasulo, V; Frantellizzi, V; De Vincentis, G; De Berardinis, E; Sciarra, A.
Advanced ureteroscopic techniques for the management of kidney stones
2021-01-01 Falagario, U. G.; Calò, B.; Auciello, M.; Carrieri, G.; Cormio, L.
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures
2021-01-01 D'Altilia, N; Mancini, V; Falagario, U; Chirico, M; Illiano, E; Balzarro, M; Annese, P; Busetto, Gm; Bettocchi, C; Cormio, L; Sanguedolce, F; Schiavina, R; Brunocilla, E; Costantini, E; Carrieri, G.
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
2022-01-01 Sanguedolce, Francesca; Zanelli, Magda; Palicelli, Andrea; Ascani, Stefano; Zizzo, Maurizio; Cocco, Giorgia; Björnebo, Lars; Lantz, Anna; Landriscina, Matteo; Conteduca, Vincenza; Falagario, Ugo Giovanni; Cormio, Luigi; Carrieri, Giuseppe
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives
2021-01-01 Tătaru, Os; Vartolomei, Md; Rassweiler, Jj; Virgil, O; Lucarelli, G; Porpiglia, F; Amparore, D; Manfredi, M; Carrieri, G; Falagario, U; Terracciano, D; de Cobelli, O; Busetto, Gm; Giudice, Fd; Ferro, M.
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
2023-01-01 Ferro, M; Crocetto, F; Barone, B; Del Giudice, F; Maggi, M; Lucarelli, G; Busetto, Gm; Autorino, R; Marchioni, M; Cantiello, F; Crocerossa, F; Luzzago, S; Piccinelli, M; Mistretta, Fa; Tozzi, M; Schips, L; Falagario, Ug; Veccia, A; Vartolomei, Md; Musi, G; de Cobelli, O; Montanari, E; Tătaru, Os.
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary?
2021-01-01 Calò, B; Sanguedolce, F; Falagario, Ug; Chirico, M; Fortunato, F; Carvalho-Diaz, E; Busetto, Gm; Bettocchi, C; Carrieri, G; Cormio, L
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators
2020-01-01 Falagario, U. G.; Martini, A.; Wajswol, E.; Treacy, P. -J.; Ratnani, P.; Jambor, I.; Anastos, H.; Lewis, S.; Haines, K.; Cormio, L.; Carrieri, G.; Rastinehad, A. R.; Wiklund, P.; Tewari, A.
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer
2021-01-01 Falagario, Ug; Recchia, M; Silecchia, G; Milillo, P; Francavilla, A; Bruno, Sm; Selvaggio, O; Busetto, Gm; Sanguedolce, F; Macarini, L; Carrieri, G; Cormio, L.
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)
2020-01-01 Falagario, Ug; Jambor, I; Lantz, A; Ettala, O; Stabile, A; Taimen, P; Aronen, Hj; Knaapila, J; Perez, Im; Gandaglia, G; Fossati, N; Martini, A; Cucchiara, V; Picker, W; Haug, E; Ratnani, P; Haines, K; Lewis, S; Sujit, N; Selvaggio, O; Sanguedolce, F; Macarini, L; Cormio, L; Nordström, T; Tewari, A; Briganti, A; Boström, Pj; Carrieri, G
Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy”
2023-01-01 Busetto, Gm; Falagario, Ug; Carrieri, G.
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
2022-01-01 Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis., Del Giudice F; Flammia, Rs; Chung, Bi; Moschini, M; Pradere, B; Mari, A; Soria, F; Albisinni, S; Krajewski, W; Szydełko, T; Laukhtina, E; D'Andrea, D; Gallioli, A; Mertens, Ls; Maggi, M; Sciarra, A; Salciccia, S; Ferro, M; Scornajenghi, Cm; Asero, V; Cattarino, S; De Angelis, M; Cacciamani, Ge; Autorino, R; Pandolfo, Sd; Falagario, Ug; D'Altilia, N; Mancini, V; Chirico, M; Cinelli, F; Bettocchi, C; Cormio, L; Carrieri, G; De Berardinis, E; Busetto, Gm
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
2023-01-01 Busetto, Gm; Finati, M; Chirico, M; Cinelli, F; D'Altilia, N; Falagario, Ug; Sanguedolce, F; Del Giudice, F; De Berardinis, E; Ferro, M; Crocetto, F; Porreca, A; Di Gianfrancesco, L; Calo', B; Mancini, V; Bettocchi, C; Carrieri, G; Cormio, L.
Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests
2019-01-01 Falagario, Ugo G; Beksac, Alp Tuna; Martini, Alberto; Cumarasamy, Shivaram; Gupta, Akriti; Prasad, Sonya; Thulasidass, Hari; Shah, Qainat N; Jayaratna, Isuru; Lewis, Sara; Rastinehad, Ardeshir R; Taouli, Bachir; Cormio, Luigi; Carrieri, Giuseppe; Tewari, Ash K
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy
2018-01-01 Cormio, Luigi; Cindolo, Luca; Troiano, Francesco; Marchioni, Michele; Di Fino, Giuseppe; Mancini, Vito; Falagario, Ugo; Selvaggio, Oscar; Sanguedolce, Francesca; Fortunato, Francesca; Schips, Luigi; Carrieri, Giuseppe
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern
2021-01-01 Sanguedolce, F; Calò, B; Chirico, M; Falagario, U; Busetto, Gm; Zanelli, M; Bisagni, A; Zizzo, M; Ascani, S; Carrieri, G; Cormio, L.
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?
2021-01-01 Falagario, Ug; Silecchia, G; Bruno, Sm; Di Nauta, M; Auciello, M; Sanguedolce, F; Milillo, P; Macarini, L; Selvaggio, O; Carrieri, G; Cormio, L
Elderly patients and prostate biopsy. How old is too old?
2018-01-01 Falagario, Ug; Sanguedolce, F; Stallone, G; D'Altilia, N; Tewari, A; Carrieri, G
Elderly patients and prostate biopsy. How old is too old?
2018-01-01 Falagario, U. G.; Sanguedolce, Null; Stallone, G.; D’Altilia, N.; Tewari, A.; Carrieri, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques | 1-gen-2022 | D'Altilia, N; Mancini, V; Falagario, Ug; Martino, L; Di Nauta, M; Calò, B; Del Giudice, F; Basran, S; Chung, Bi; Porreca, A; Bianchi, L; Schiavina, R; Brunocilla, E; Busetto, Gm; Bettocchi, C; Annese, P; Cormio, L; Carrieri, G. | |
| A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data | 1-gen-2021 | Maggi, M; Salciccia, S; Del Giudice, F; Busetto, Gm; Falagario, Ug; Carrieri, G; Ferro, M; Porreca, A; Di Pierro, Gb; Fasulo, V; Frantellizzi, V; De Vincentis, G; De Berardinis, E; Sciarra, A. | |
| Advanced ureteroscopic techniques for the management of kidney stones | 1-gen-2021 | Falagario, U. G.; Calò, B.; Auciello, M.; Carrieri, G.; Cormio, L. | |
| Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures | 1-gen-2021 | D'Altilia, N; Mancini, V; Falagario, U; Chirico, M; Illiano, E; Balzarro, M; Annese, P; Busetto, Gm; Bettocchi, C; Cormio, L; Sanguedolce, F; Schiavina, R; Brunocilla, E; Costantini, E; Carrieri, G. | |
| Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation | 1-gen-2022 | Sanguedolce, Francesca; Zanelli, Magda; Palicelli, Andrea; Ascani, Stefano; Zizzo, Maurizio; Cocco, Giorgia; Björnebo, Lars; Lantz, Anna; Landriscina, Matteo; Conteduca, Vincenza; Falagario, Ugo Giovanni; Cormio, Luigi; Carrieri, Giuseppe | |
| Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives | 1-gen-2021 | Tătaru, Os; Vartolomei, Md; Rassweiler, Jj; Virgil, O; Lucarelli, G; Porpiglia, F; Amparore, D; Manfredi, M; Carrieri, G; Falagario, U; Terracciano, D; de Cobelli, O; Busetto, Gm; Giudice, Fd; Ferro, M. | |
| Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review | 1-gen-2023 | Ferro, M; Crocetto, F; Barone, B; Del Giudice, F; Maggi, M; Lucarelli, G; Busetto, Gm; Autorino, R; Marchioni, M; Cantiello, F; Crocerossa, F; Luzzago, S; Piccinelli, M; Mistretta, Fa; Tozzi, M; Schips, L; Falagario, Ug; Veccia, A; Vartolomei, Md; Musi, G; de Cobelli, O; Montanari, E; Tătaru, Os. | |
| Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? | 1-gen-2021 | Calò, B; Sanguedolce, F; Falagario, Ug; Chirico, M; Fortunato, F; Carvalho-Diaz, E; Busetto, Gm; Bettocchi, C; Carrieri, G; Cormio, L | |
| Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators | 1-gen-2020 | Falagario, U. G.; Martini, A.; Wajswol, E.; Treacy, P. -J.; Ratnani, P.; Jambor, I.; Anastos, H.; Lewis, S.; Haines, K.; Cormio, L.; Carrieri, G.; Rastinehad, A. R.; Wiklund, P.; Tewari, A. | |
| Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer | 1-gen-2021 | Falagario, Ug; Recchia, M; Silecchia, G; Milillo, P; Francavilla, A; Bruno, Sm; Selvaggio, O; Busetto, Gm; Sanguedolce, F; Macarini, L; Carrieri, G; Cormio, L. | |
| Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) | 1-gen-2020 | Falagario, Ug; Jambor, I; Lantz, A; Ettala, O; Stabile, A; Taimen, P; Aronen, Hj; Knaapila, J; Perez, Im; Gandaglia, G; Fossati, N; Martini, A; Cucchiara, V; Picker, W; Haug, E; Ratnani, P; Haines, K; Lewis, S; Sujit, N; Selvaggio, O; Sanguedolce, F; Macarini, L; Cormio, L; Nordström, T; Tewari, A; Briganti, A; Boström, Pj; Carrieri, G | |
| Commentary on “Clinical implications of endogenous testosterone density in prostate cancer progression in patients with favorable low and intermediate risk treated with radical prostatectomy” | 1-gen-2023 | Busetto, Gm; Falagario, Ug; Carrieri, G. | |
| Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis | 1-gen-2022 | Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis., Del Giudice F; Flammia, Rs; Chung, Bi; Moschini, M; Pradere, B; Mari, A; Soria, F; Albisinni, S; Krajewski, W; Szydełko, T; Laukhtina, E; D'Andrea, D; Gallioli, A; Mertens, Ls; Maggi, M; Sciarra, A; Salciccia, S; Ferro, M; Scornajenghi, Cm; Asero, V; Cattarino, S; De Angelis, M; Cacciamani, Ge; Autorino, R; Pandolfo, Sd; Falagario, Ug; D'Altilia, N; Mancini, V; Chirico, M; Cinelli, F; Bettocchi, C; Cormio, L; Carrieri, G; De Berardinis, E; Busetto, Gm | |
| Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? | 1-gen-2023 | Busetto, Gm; Finati, M; Chirico, M; Cinelli, F; D'Altilia, N; Falagario, Ug; Sanguedolce, F; Del Giudice, F; De Berardinis, E; Ferro, M; Crocetto, F; Porreca, A; Di Gianfrancesco, L; Calo', B; Mancini, V; Bettocchi, C; Carrieri, G; Cormio, L. | |
| Defining Prostate Cancer at Favorable Intermediate Risk: the Potential Utility Of Magnetic Resonance Imaging And Genomic Tests | 1-gen-2019 | Falagario, Ugo G; Beksac, Alp Tuna; Martini, Alberto; Cumarasamy, Shivaram; Gupta, Akriti; Prasad, Sonya; Thulasidass, Hari; Shah, Qainat N; Jayaratna, Isuru; Lewis, Sara; Rastinehad, Ardeshir R; Taouli, Bachir; Cormio, Luigi; Carrieri, Giuseppe; Tewari, Ash K | |
| Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy | 1-gen-2018 | Cormio, Luigi; Cindolo, Luca; Troiano, Francesco; Marchioni, Michele; Di Fino, Giuseppe; Mancini, Vito; Falagario, Ugo; Selvaggio, Oscar; Sanguedolce, Francesca; Fortunato, Francesca; Schips, Luigi; Carrieri, Giuseppe | |
| Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern | 1-gen-2021 | Sanguedolce, F; Calò, B; Chirico, M; Falagario, U; Busetto, Gm; Zanelli, M; Bisagni, A; Zizzo, M; Ascani, S; Carrieri, G; Cormio, L. | |
| Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? | 1-gen-2021 | Falagario, Ug; Silecchia, G; Bruno, Sm; Di Nauta, M; Auciello, M; Sanguedolce, F; Milillo, P; Macarini, L; Selvaggio, O; Carrieri, G; Cormio, L | |
| Elderly patients and prostate biopsy. How old is too old? | 1-gen-2018 | Falagario, Ug; Sanguedolce, F; Stallone, G; D'Altilia, N; Tewari, A; Carrieri, G | |
| Elderly patients and prostate biopsy. How old is too old? | 1-gen-2018 | Falagario, U. G.; Sanguedolce, Null; Stallone, G.; D’Altilia, N.; Tewari, A.; Carrieri, G. |